Skip to main content
Hikal Ltd. logo

Hikal Ltd. — Investor Relations & Filings

Ticker · HIKAL ISIN · INE475B01022 LEI · 335800OLTGHHYZWTF859 BSE.NS Manufacturing
Filings indexed 735 across all filing types
Latest filing 2021-07-20 Regulatory Filings
Country IN India
Listing BSE.NS HIKAL

About Hikal Ltd.

https://www.hikal.com

Hikal Ltd. provides solutions across the life sciences value chain, specializing in the development and manufacturing of active ingredients, intermediates, and formulations. The company operates through two primary business segments: Pharmaceuticals and Crop Protection. In the pharmaceutical division, it focuses on the production of Active Pharmaceutical Ingredients (APIs) and advanced intermediates for various therapeutic areas. The crop protection segment involves the contract manufacturing of pesticides, herbicides, and fungicides for global agrochemical leaders. Hikal offers comprehensive Contract Research and Manufacturing Services (CRAMS), leveraging its research and development capabilities to support clients from early-stage development to commercial-scale production. Its facilities adhere to international quality standards, maintaining a strong track record of regulatory compliance with global health authorities.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2021. It is a confirmation certificate from the Registrar and Share Transfer Agent regarding securities dematerialized/rematerialized during the quarter. The document is dated July 20, 2021, and is addressed to stock exchanges for compliance purposes. The content is a regulatory compliance certificate rather than a financial report or announcement of financial results. The document length is 3057 characters, which is relatively short and consistent with a certificate or attestation. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance certificate and not a full financial report or announcement.
2021-07-20 English
Trading Window
Regulatory Filings Classification · 90% confidence The document text is extremely short (132 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report title, no regulatory references, or any indication of the document's purpose. Given the lack of content, it cannot be classified as a report or announcement of a report. According to the rules, such minimal content with no meaningful information defaults to Regulatory Filings (RNS) as a fallback category.
2021-06-30 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements, 2015. It provides an update about the resumption of manufacturing at a facility due to the availability of industrial oxygen. The letter is dated June 10, 2021, and references a prior letter dated May 19, 2021. The content is an operational update related to manufacturing activities and supply chain issues, not a financial report, earnings release, or regulatory filing of financial data. It is a regulatory announcement informing the exchanges and investors about a material event affecting operations. The document length is short (1892 characters), and it is not a report or financial statement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-06-10 English
Related Party Transactions
Annual Report Classification · 85% confidence The document contains detailed related party disclosures including lists of subsidiaries, key management personnel, and transactions such as remuneration, commissions, sitting fees, dividends, and lease rent paid. These disclosures are typical notes found within a company's financial statements or annual report. The document is 3488 characters long, which is relatively short and does not appear to be an announcement or a brief summary. It contains substantive financial data related to related party transactions, which are usually part of the annual financial reporting. There is no indication that this is a standalone audit report, management change announcement, or any other specific filing type. Therefore, the document is best classified as part of an Annual Report (10-K) or equivalent comprehensive financial report containing detailed financial disclosures.
2021-06-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is extremely short (142 characters) and contains no substantive financial data, analysis, or detailed information. It appears to be a minimal notice or placeholder with a date and organizer name only, without any report content or detailed announcement. There is no indication of financial results, management changes, voting results, or any other specific filing content. Given the brevity and lack of detail, this document best fits the category of a Regulatory Filing (RNS), which serves as a fallback for miscellaneous or minimal filings that do not fit other categories.
2021-05-28 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the impact of nonavailability of industrial oxygen on production and sales, specifically mentioning a disruption due to COVID-19 related government directives. The content is an update on operational impact and regulatory compliance disclosure rather than a financial report, earnings release, or management discussion. The document length is short (2697 characters) and it is an announcement of a material event affecting the company, fitting the profile of a general regulatory announcement. Therefore, it best fits the category of Regulatory Filings (RNS).
2021-05-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.